Research Projects

• Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) International Clinical Database and Repository Collaborative Registry, 2013 - present
• Analytical Performance and Clinical Associations of Non-Criteria Antibodies to Neutral and Negatively Charged Phospholipids in Antiphospholipid Syndrome, 2016-present.
• Evaluation of the native, mutant, and PEGylated forms of the small peptide TIFI in preventing antiphospholipid mediated thrombosis, Industry-sponsored, 2020-present
• Persistence And Titer of Antiphospholipid Antibodies As Indicators Of Disease Risk In Antiphospholipid Syndrome, 2021-present
• Impact of Testing Method and Analyte on the Diagnosis of Antiphospholipid Syndrome: Collaboration with The Association of Medical Laboratory Immunologists, 2021-present
• Simulators to improve Confidence in performing Joint Injections. Feb 2021 - present. 
• Daratumumab in Primary Antiphospholipid Syndrome (DARE-APS), NIAID-sponsored, 2023-present
• 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria Solid Phase-based Antiphospholipid Antibody (aPL) Domain - Collaborative Efforts of APS ACTION and ISTH-SSC to Harmonize ELISA and non-ELISA aPL Tests, 2024 - present
• Multicenter evaluation of Taipan Ecarin Lupus Anticoagulant Assay in the evaluation of anticoagulated aPL-positive patients (APS ACTION), 2024 - present
• The role of non-criteria negatively charged aPL assays in determining Lupus Anticoagulant activity, 2025 - present